Teva
Presenting partner
Information
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for 120 Years. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area.
Around 200 million people around the world take a Teva medicine every day, are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Teva operated 32 manufacturing and research and development facilities across Europe in 2020.
In Europe, Teva’s local purchases and payroll across the nine key markets supported nearly 105,000 jobs, contributed $29.5 billion (€25.8 billion) to economic output, and generated $5.6 billion (€4.9 billion) in labor income. Teva’s generic medicines saved healthcare systems across nine European countries $9.6 billion (€8.4 billion) in 2020. Learn more about Teva and its Economic Impact .
